The last data published by Chandra et al. [54] and Chandra and Pahan [55] demonstrated that activators of PPAR-α (cinnamic acid and gemfibrozil) decrease amyloid plaque in the hippocampus and cortex in the animal model of AD (5XFAD). The gene discussed is PPARA; the disease is Alzheimer disease.